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Background: The aim of the present national prospective population-based study was to assess the early morbidity
of esophageal atresia (EA).
Methods: All 38 multidisciplinary French centers that care for patients with EA returned a specific questionnaire
about the 1-year outcome for each patient. This information was centralized, checked, and entered into a database.
Results: From the total population of 307 EA patients born in 2008 and 2009, data about the 1-year outcome were
obtained from 301 (98%) patients, of whom 4% were lost to follow-up and 5% died. Medical complications occurred in
34% of the patients: anastomotic leaks (8%), recurrent tracheoesophageal fistula (4%), and anastomotic stenosis (22%);
all of the latter group needed dilation (median, 2 dilations/patient). A new hospitalization was required for 59% of
patients (2.5 hospitalizations/patient) for digestive (52%) or respiratory (48%) reasons. Twelve percent of patients
required antireflux surgery at a median age of 164 days (range, 33–398 days), and 1% underwent an aortopexy for
severe tracheomalacia. The weight/age Z-score was −0.8 (range, −5.5 to 3.7 months) at 12 months. Fifteen percent
of patients were undernourished at 12 months of age, whereas 37% presented with respiratory symptoms and 15%
had dysphagia at the last follow-up. Significant independent factors associated with medical complications were
anastomotic esophageal tension (p = .0009) and presence of a gastrostomy (p = .0002); exclusive oral feeding at
discharge was associated with a decreased risk of complications (p = .007).
Conclusions: Digestive and respiratory morbidities remain frequent during the first year of life and are associated
with difficult anastomosis and lack of full oral feeding.
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Esophageal atresia (EA) with or without a tracheoesopha-
geal fistula (TEF) is a rare congenital malformation
(MIM 189960) [1,2]. In 2012, the EUROCAT Working
Group (23 European registries of congenital anomalies)
published an overall prevalence of 2.4 per 10 000 births
with important regional differences [3]. A prospective
population-based register was initiated in 2008 and
included all the centers that care for EA patients in
France. This register showed that the live-birth prevalence
of EA was 1.8 per 10 000 births in our country [4].
The prognosis of EA has benefited from advances in
medical care, including neonatal and surgical procedures,
and has therefore improved significantly over the past
three decades. Its survival rate now exceeds 95% and an
increasing number of patients reach adulthood [3,4].
However, retrospective monocentric studies from tertiary
centers have reported respiratory and digestive/nutritional
problems both in early infancy and at long-term follow-up
[5]. Updated information on the outcome of EA from
population-based studies is lacking.
In the present study, we report the first-year outcome
of all EA patients included in the French register over a
2-year period, as well as factors that were associated
with morbidity.
Methods
A network of all the centers in France that treat EA was
created in 2006 within the framework of the French
national plan for rare diseases, and this network is coordi-
nated by the National Reference Center for EA located at
the Lille University Hospital. A population-based registry of
EA was created and began to collect data prospectively on
all patients born with EA in France from January 1, 2008.
The register was approved by the National Informatics and
Privacy Committee (CNIL), and was qualified by the
National Committee of Register (InVs, CNR). All data were
used anonymously, and the parents were informed about
the aims of the register. Two specific questionnaires
collected information at birth and at 1 year of age [see
Additional file 1]. These questionnaires were validated by a
multidisciplinary national committee of experts, including
epidemiologists, neonatologists, surgeons, and pediatricians.
The questionnaires were completed by the participating
centers on a voluntary basis. A clinical research assistant
helped to collect the information at each center, when
required. A physician and a research assistant checked each
questionnaire and double-checked the data entered into the
database. When inconsistencies or lack of information were
found, the corresponding center was contacted to resolve
the issue. The methodology and exhaustivity of the register
have been reported elsewhere [4].
The present study concerned the first-year outcome of
all EA patients included in the registry who were bornbetween January 1, 2008, and December 31, 2009. EA was
classified according to Ladd’s classification [6]. Data
collected included general neonatal characteristics of the
patient and outcome up to 1 year of age: death, post-
surgical direct esophageal complications and chronic
complications, new hospitalization and causes, and nutri-
tion status at 6 and 12 months evaluated by the Z-score for
weight/age. Undernutrition was defined as a Z-score ≤ −2.0
standard deviation (SD). A medical complication was de-
fined as the occurrence of anastomotic leaks (radiological
leaks), recurrent TEF, or anastomotic stenosis needing
esophageal dilation. The presence of esophageal anasto-
motic tension, difficulty in performing anastomosis and
timing of primary or delayed primary repair were decided
by the surgeon. The variable time to esophageal anasto-
mosis was recorded separately for patients receiving a
primary anastomosis (during the neonatal period) and
those receiving a delayed primary anastomosis (after a few
weeks). Respiratory symptoms were defined as recurrent
lung infections or chronic wheezing or recurrent episodes
of bronchiolitis, and dysphagia as difficulty in swallowing.
Statistical analyses
Continuous variables were analyzed using Student’s t test
or Wilcoxon’s rank-sum test in cases of heteroscedasticity
or nonnormality. Categorical variables were analyzed
using Fisher’s exact test. The variables with a p-value <0.2
in a univariate analysis and all variables potentially
associated with the complication based on clinical
knowledge were used in a multivariate logistic regression
only if the missing data were less than 30% for the
variable. The selection of the variables in the final model
was made using backward elimination. The type I error was
set at 5% (two-sided) for all statistical tests. R software,
version 3.1.0, was used for data analysis.
Results
From the total population of 307 EA patients born in
2008 and 2009 in France, data about the 1-year outcome
were obtained from 301 (98%) patients, of whom 4%
(n = 12) were lost to follow-up and 5% died (n = 16).
The first-year outcome was available for 275 patients
(90%), and their general neonatal characteristics are
summarized in Table 1.
A total of 16 patients (5%) died during the first year of
follow-up, at a median age of 13 days (range, 1–284 days).
The causes of death were the consequences of associated
malformations or complications of surgery (Table 2).
During the first year of follow-up, rehospitalization
was required for 59% (160/272) of the patients, with a mean
number of hospitalizations of 2.5/patient (±2.0; range,
1.0–13.0 hospitalizations) and a mean hospital stay of
21 days (±37; range, 1–365 days). The main causes
of hospitalization were digestive in 52% of patients




Term 37 ± 3 weeks
Birth weight 2591 ± 699 g
LADD I [6] 9%
LADD III [6] 87%
Other EA types [6] II: 1.0%; IV: 1.5%; V: 1.5%
Associated malformation 48%
Delayed primary anastomosis 13%
Defect length 1.9 ± 1.4 cm
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nutritional evaluation, anorectal malformation surgery,
pyloric stenosis, and gastroenteritis…) and respiratory in
48% of patients (e.g., bronchiolitis, respiratory infection,
and tracheomalacia…).
A medical complication, as defined previously, occurred
in 34% (91/271) of the patients: anastomotic leaks (8%),
recurrent TEF (4%), and anastomotic stenosis (22%)
needing esophageal dilation in 22% of patients (2.3
dilations/patient; range, 1.0–9.0 dilations; at a mean age
of 123 days (range, 20–360 days) for the first dilation).
Twelve percent of patients required antireflux surgery at a
median age of 164 days (range, 33–398 days), and 1% of
patients required an aortopexy for severe tracheomalacia
(median age, 122 days; range, 75–238 days).
The percentage of patients receiving a gastrostomy in our
1-year follow-up population was 22%. Most gastrostomiesTable 2 Ages and causes of death
Age at death (days) Term (weeks) Birth weight (g
1 ? 39 2300
2 1 37 2770
3 1 31 1750
4 2 34 1760
5 2 39 1840
6 3 36 2100
7 6 36 1985
8 6 34 1815
9 13 28 600
10 20 35 2380
11 53 30 1295
12 102 32 1300
13 151 34 1101
14 182 38 2190
15 192 36 2920
16 284 37 2800were placed surgically at birth in cases of delayed anasto-
mosis for pure EA or for long defects in type III patients. In
some cases, patients with pure EA or type III EA (e.g., with
prematurity) underwent primary anastomosis associated
with a systematic gastrostomy depending on the local
team’s experience. The weight/age Z-score was 0.1
(range, −5.1 to 5.5; ±2.0) at 6 months and −0.8
(range, −5.5 to 3.7; ±1.2) at 12 months. Fifteen percent of
patients were undernourished at the ages of 6 and
12 months, whereas 37% presented with respiratory
symptoms and 15% had dysphagia at the last follow-up.
Comparative analyses of the children who presented
with at least one complication (n = 91) compared with
those with no complications (n = 180) are summarized
in Table 3. Significant independent factors that were
associated with a medical complication during the
first-year follow-up were anastomotic esophageal tension
(56% vs 44%; OR, 3.0 [1.6–5.6] p = .0009), presence of a
gastrostomy (71% vs 29%; OR, 4.8 [2.1–11.1] p = .0002);
exclusive oral feeding at discharge was associated with
a decrease risk of complication (74% vs 26%; OR, 4.5
[1.5–14.2] p = .007). Factors such as prematurity, low
birth weight, pure EA, and associated malformations
were not significantly associated with complications.
Discussion
The survival rate of EA in developed countries reached a
plateau in the 1980s and seems to be currently stable at
around 95% [2,3]. Major cardiac malformations and low
birth weight (<1500 g) are two predictors identified by
Spitz using the modification of Waterston’s risk-group
classification, and these risk factors are consistent with) EA type (LADD) Cause of death













III Cardiac failure (sepsis)
I Mediastinitis
III Sudden infant death (negative autopsy)






Sex (%) Male (31) Male (69) .8 NS
Female (29) Female (71)
Term (weeks) 36.5 ± 3.3 37.6 ± 2.9 .005 NS
Birth weight (g) 2419 ± 710 2672 ± 677 .003 NS
Associated malformations (%) 57/141 (40) 84/141 (60) .01 NS
EA type (%) LADD I (64) LADD I (36) .01 NS
LADD III (29) LADD III (71)
Defect length 1.6 ± 4.8 1.5 ± 1.2 .0002 NS
Primary anastomosis (%) 70/235 (30) 165/235 (70) .003 NS
Delayed primary anastomosis (%) 22/32 (69) 10/32 (31) 1.4 10−5 NS
Anastomotic tension (%) 48/86 (56) 38/86 (44) 1.2 10−7 OR, 3.0 [1.6–5.6] p = .0009
Difficult anastomosis (%) 16/28 (57) 12/28 (43) .01 NS
Gastrostomy (%) 40/56 (71) 16/56 (29) 4.9 10−11 OR, 4.8 [2.1–11.1] p = .0002
Complementary enteral nutrition at discharge (%) 28/40 (70) 12/40 (30) 2.9 10−7 NS
Exclusive oral feeding at discharge (%) 57/219 (26) 162/219 (74) 3.1 10−6 OR, 4.5 [1.5-14.2] p = .007
NS, not significant.
OR, odds-ratio.
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Death occurred during the first days of life in most of
those who died (Table 2).
Our data from a population-based register show that
more than one-third of patients operated on for EA had
medical complications. Comparisons with the literature are
difficult because the definition of complications differs
between studies. For example, in a retrospective
monocentric series, Castilloux et al. reported that
more than half of their patients had a complicated
evolution, but they considered severe gastroesophageal
reflux confirmed at biopsy or severe chronic respiratory
disease as complicated issues [8]. We decided to consider
only reliable and objective complications to homogenize
the results because the register involves 38 different
centers and investigators. This showed clearly that
despite recent advances in neonatal care and surgical
techniques, morbidity remains high within the first year of
life of EA patients.
Our study also showed that these patients required
frequent rehospitalization during the first year compared
with a previous study that reported a 67% hospitalization
rate [9]. As expected, digestive and respiratory problems
were the main causes of hospitalization [10]. Parents
should be informed about this issue.
Complications directly related to esophageal anasto-
mosis remain frequent, despite recent surgical progress
[2,8,11-14]. Similarly, gastroesophageal reflux remains a
major problem, as 10–20% of patients needed antireflux
surgery within the first year of life [2,13,14].Respiratory complications are also a major concern in
children with EA and represent an important factor re-
lated to morbidity; respiratory disease at 1 year of age
has been reported in 9% of patients [8]. These com-
plications are often underestimated, and a systematic first-
year survey found respiratory symptoms in 37% of our
patients.
Nutritional status is rarely reported in EA populations,
and data are lacking particularly in the first year of life.
For example, Chetcuti et al. reported malnutrition in 13%
of their patients with EA aged 1–37 years, of whom two-
thirds were younger than 5 years [9]. Other authors have
reported a growth delay in nearly one-third of these
children at the age of 5 years [13]. All reported data apply
only to older children with EA. Fifteen percent of our
patients were undernourished at 6 and 12 months of life,
which indicated that malnutrition did not decrease between
6 and 12 months of age despite earlier nutritional support.
One of the main results of our study was the identifica-
tion of three independent predictors of complications. One
neonatal factor was linked to the malformation and surgical
procedure (esophageal anastomotic tension), and two
nutritional factors were significantly related to the occur-
rence of complications. Anastomotic tension may favor
gastroesophageal reflux and esophageal stenosis, whereas
gastrostomy and enteral nutrition (naso-gastric tube) are
often necessary in more difficult cases with esophageal
dysmotility or anastomotic stenosis resulting in delayed
food intake or malnutrition. Although anastomotic tension
could not be evaluated using an objective methodology, we
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because this information was recorded prospectively with-
out knowledge of the outcomes. Pure EA, prematurity,
and associated malformations, which were associated with
complications in previous studies, were not significant
in the present study; however, our study might have
been underpowered regarding these factors.
The purpose of identifying the early predictors of
morbidity/mortality is to identify patients who require
more intensive follow-up programs [8]. Because the
survival rate has improved, these children with EA
will gradually enter adulthood with significant esophageal
morbidity [15]. Most of the teams that currently treat
children with EA abandoned the original idea of “complete
healing” once surgical anastomosis has been performed,
and it is now suggested that the crucial role of multidiscip-
linary specialist clinics should be the long-term follow-up
of these patients [13].
To our knowledge, this was the first prospective national
registry to focus specifically on EA with a national dimen-
sion. One of the key points of this type of registry is its
exhaustiveness, with few patients lost to follow-up and a
large number of patients included in the analyses, which
resulted in high statistical power. Some of the variables
studied can be center dependent. However, the multicentric
characteristic of our registry limits this bias and reflects the
reality at a population level because the registry was not
limited to selected populations from tertiary centers.
The results obtained from our population-based registry
are important for health-care providers who are involved
in prenatal and neonatal care because they may help to
inform, and to provide better counseling to the parents of
a fetus or newborn affected by EA.
Conclusions
In conclusion, although mortality was low, digestive and
respiratory morbidities were frequent in the first year
after EA repair and often required rehospitalization. This
situation is associated with high health costs and has
social and psychological effects on the relatives of
these children. Information provided to the parents
should be adapted to highlight these risks. EA follow-up is
necessary, especially during the first year of life. High-risk
groups of patients were identified.
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